AELIP

Asociación AELIP

Top of Page
Menu
Español English Deutsch Francaise

Publicaciones

1. Early atherosclerosis in Familial Partial Lipodystrophy of the Dunnigan-type: Endothelial cell dysfunction induced by p.R482W lamin-A  Guillaume Bidault, Marie Garcia, Marie-Christine Vantyghem, Pierre-Henri Ducluzeau, Romain Morichon, Kayathri Thiyagarajah, Sylviane Moritz, Jacqueline Capeau, Corinne Vigouroux, and Véronique Béréziat ATVB in revision


2. How to diagnose a lipodystrophy syndrome.  Vantyghem MC, Balavoine AS, Douillard C, Defrance F, Dieudonne L, Mouton F, Lemaire C, Bertrand-Escouflaire N, Bourdelle-Hego MF, Devemy F, Evrard A, Gheerbrand D, Girardot C, Gumuche S, Hober C, Topolinski H, Lamblin B, Mycinski B, Ryndak A, Karrouz W, Duvivier E, Merlen E, Cortet C, Weill J, Lacroix D, Wémeau JL. Ann Endocrinol (Paris). 2012 Jun;73(3):170-89. 

3. LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue.  Béréziat V, Cervera P, Le Dour C, Verpont MC, Dumont S, Vantyghem MC, Capeau J, Vigouroux C; Lipodystrophy Study Group. Am J Pathol. 2011 Nov;179(5):2443-53.. 

4. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.  Vantyghem MC, Vincent-Desplanques D, Defrance-Faivre F, Capeau J, Fermon C, Valat AS, Lascols O, Hecart AC, Pigny P, Delemer B, Vigouroux C, Wemeau JL. J Clin Endocrinol Metab. 2008 Jun;93(6):2223-9. Free Article

5. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. Decaudain A, Vantyghem MC, Guerci B, Hécart AC, Auclair M, Reznik Y, Narbonne H, Ducluzeau PH, Donadille B, Lebbé C, Béréziat V, Capeau J, Lascols O, Vigouroux C. J Clin Endocrinol Metab. 2007 Dec;92(12):4835-44.  Free Article

6. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism. Vantyghem MC, Faivre-Defrance F, Marcelli-Tourvieille S, Fermon C, Evrard A, Bourdelle-Hego MF, Vigouroux C, Defebvre L, Delemer B, Wemeau JL. Clin Endocrinol (Oxf). 2007 Aug;67(2):247-9. 

7. .[Monogenic severe insulin resistance syndromes]. Vincent-Desplanques D, Faivre-Defrance F, Wémeau JL, Vantyghem MC. Rev Med Interne. 2005 Nov;26(11):866-73. Review. French. 


8. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. Vantyghem MC, Pigny P, Maurage CA, Rouaix-Emery N, Stojkovic T, Cuisset JM, Millaire A, Lascols O, Vermersch P, Wemeau JL, Capeau J, Vigouroux C. J Clin Endocrinol Metab. 2004 Nov;89(11):5337-46. Free Article

9. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Vigouroux C, Magré J, Vantyghem MC, Bourut C, Lascols O, Shackleton S, Lloyd DJ, Guerci B, Padova G, Valensi P, Grimaldi A, Piquemal R, Touraine P, Trembath RC, Capeau J. Diabetes. 2000 Nov;49(11):1958-62. 

10. Vantyghem MC.

Lipodystrophy partial familial, associated with PPARG mutation, AKT2 mutation  Köbberling type

Acquired generalized lipodystrophy, Acquired partial lipodystrophy

Lipomatose symétrique  familiale

Lipodystrophy in Human Immunodeficiency Virus Infected Patient

Dysplasie acro-mandibulaire

Encyclopédie ORPHANET- ORPHANET INSERM SC11 2006

Publicaciones
Este sitio web utiliza cookies para facilitar y mejorar la navegación. Si continúas navegando, consideramos que aceptas su uso. POLITICA DE COOKIES